Implantierbarer Kardioverter Defibrillator

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44]

Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

1 Bibliographie

  1. ↑ Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 147(4):251-62 (2007) PMID 17709759
  2. ↑ Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 138(6):445-52 (2003) PMID 12639076
  3. ↑ The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death. Ann Intern Med 133(11):901-10 (2000) PMID 11103061
  4. ↑ Implantable cardioverter-defibrillators: implications for the nonelectrophysiologist. Ann Intern Med 122(10):770-7 (1995) PMID 7717600
  5. ↑ Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease. Circ Arrhythm Electrophysiol 1(4):307-16; discussion 316 (2008) PMID 19808423
  6. ↑ Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator. Circ Arrhythm Electrophysiol 1(4):298-306 (2008) PMID 19808422
  7. ↑ Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 117(20):2608-16 (2008) PMID 18458170
  8. ↑ Highlighting the R in CRT. Circulation 116(13):1434-6 (2007) PMID 17893284
  9. ↑ Sudden death prevention with implantable devices. Circulation 116(5):561-71 (2007) PMID 17664385
  10. ↑ ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(10):e385-484 (2006) PMID 16935995
  11. ↑ Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy. Circulation 111(24):3327-35 (2005) PMID 15967863
  12. ↑ Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Circulation 111(19):2537-49; discussion 2537-49 (2005) PMID 15900623
  13. ↑ Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Circulation 111(19):2537-49; discussion 2537-49 (2005) PMID 15897357
  14. ↑ MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. Circulation 108(15):1779-83 (2003) PMID 14557341
  15. ↑ ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106(16):2145-61 (2002) PMID 12379588
  16. ↑ The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 92(6):1651-64 (1995) PMID 7664453
  17. ↑ Clinical investigation of antiarrhythmic devices. A statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Circulation 91(7):2097-109 (1995) PMID 7895372
  18. ↑ Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review. Eur Heart J 28(4):469-77 (2007) PMID 17227788
  19. ↑ ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 27(17):2099-140 (2006) PMID 16923744
  20. ↑ MADIT-II and its implications. Eur Heart J 24(1):16-8 (2003) PMID 12559932
  21. ↑ Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Eur Heart J 22(13):1074-81 (2001) PMID 11428848
  22. ↑ Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Eur Heart J 21(24):2071-8 (2000) PMID 11102258
  23. ↑ Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. Eur Heart J 18(1):26-30 (1997) PMID 9049512
  24. ↑ Primary prevention of sudden cardiac death. Heart 92(12):1873-8 (2006) PMID 17105896
  25. ↑ The MADIT II and COMPANION studies: will they affect uptake of device treatment? Heart 90(3):243-5 (2004) PMID 14966031
  26. ↑ Implantable cardioverter-defibrillator treatment and resynchronisation in heart failure. Heart 90(2):231-4 (2004) PMID 14729810
  27. ↑ An audit of the implications of implementing NICE guidance on the use of implantable cardioverter-defibrillators. Heart 89(7):787-8 (2003) PMID 12807860
  28. ↑ Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness. Heart 87(5):438-42 (2002) PMID 11997415
  29. ↑ Indications for an implantable cardioverter defibrillator (ICD). Intern Med 43(5):360-7 (2004) PMID 15206546
  30. ↑ American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 52(14):1179-99 (2008) PMID 18804749
  31. ↑ Benefits of the implantable cardioverter-defibrillator. J Am Coll Cardiol 52(14):1122-7 (2008) PMID 18804737
  32. ↑ A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 52(14):1111-21 (2008) PMID 18804736
  33. ↑ Azimilide: another effort to prevent implantable cardioverter-defibrillator shocks and their sequelae why it is important and how it works. J Am Coll Cardiol 52(13):1084-5 (2008) PMID 18848142
  34. ↑ ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51(21):e1-62 (2008) PMID 18498951
  35. ↑ Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 51(3):288-96 (2008) PMID 18206738
  36. ↑ Evaluation and management of patients after implantable cardioverter-defibrillator shock. JAMA 296(23):2839-47 (2006) PMID 17179461
  37. ↑ Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 292(23):2874-9 (2004) PMID 15598919
  38. ↑ Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure. Postgrad Med J 82(963):16-23 (2006) PMID 16397075
  39. ↑ Therapy with an implantable cardioverter defibrillator (ICD) in patients with coronary artery disease and dilated cardiomyopathy: benefits and disadvantages. Swiss Med Wkly 139(45-46):647-53 (2009) PMID 19950031
  40. ↑ ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48(5):e247-346 (2006) PMID 16949478
  41. ↑ Implantable cardioverter-defibrillator therapy in clinical practice. J Am Coll Cardiol 47(8):1507-17 (2006) PMID 16630984
  42. ↑ Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 44(11):2166-72 (2004) PMID 15582314
  43. ↑ Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators. J Am Coll Cardiol 43(1):44-6 (2004) PMID 14715181
  44. ↑ Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol 41(9):1573-82 (2003) PMID 12742300

2 Andere Lexika

Abgerufen von „http://de.pluspedia.org/w/index.php?title=Implantierbarer_Kardioverter_Defibrillator&oldid=41109“

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook


Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway